6 documents found, page 1 of 1

A Portuguese expert panel position paper on the management of heart failure wit...

Funding Information: Ana Santos of Prime Focus provided medical writing, editorial support, and formatting assistance, which was contracted and funded by Boehringer Ingelheim and Lilly Portugal. Publisher Copyright: © 2025; Heart failure (HF) with preserved ejection fraction (HFpEF) affects more than 50% of HF patients worldwide, and more than 70% of HF patients aged over 65. This is a complex syndrome with a c...

A Portuguese expert panel position paper on the management of heart failure wit...

Funding Information: Ana Santos of Prime Focus provided medical writing, editorial support, and formatting assistance, which was contracted and funded by Boehringer Ingelheim and Lilly Portugal. Publisher Copyright: © 2025; In Portugal, a 15.2% prevalence of heart failure with preserved ejection fraction (HFpEF) was recently identified among those aged ≥50 years. HFpEF represents 90% of Portuguese heart failure...

Perceptions of cardiology, professional preferences and impact on career choice...

Introduction and Objectives: Cardiology has not been seen as an attractive specialty, and women have avoided it for many years. Some surveys have been performed in other countries, but in Portugal, the situation is largely unknown. Methods: An online survey on perceptions of cardiology and professional preferences was sent to 1371 members of the Portuguese Society of Cardiology, of whom 18.2% completed the surv...

Investigação Clínica da Iniciativa do Investigador em Portugal

Estudo de Prevalência de Insuficiência Cardíaca em Portugal (PORTHOS), fundamen...

Funding Information: PORTHOS study arises from a scientific partnership between the Portuguese Society of Cardiology, AstraZeneca and NOVA Medical School. The authors are especially grateful to all the institutional partners that collaborated at various levels: Associação de Apoio aos Doentes com Insuficiência Cardíaca (AADIC), GlobalSports, Maria Design, Missão Continente (Sonae), Unilabs and GE. For the colla...

Heterogeneity amongst GLP-1 RA cardiovascular outcome trials results

Funding Information: MM participated in advisory board meetings and received speaker’s fees from the following companies: AstraZeneca, Bial, Boeringher-Ingelheim, Lilly, NovoNordisk and Sanofi. CG reports consulting and speaking fees from Astrazeneca, Novo Nordisk, Lilly, Boheringer Ingelheim, MSD and Bayer. JSN reports receiving research funding from AstraZeneca, and Merck sa; and consulting/speaker’s fees fro...